Volumetric 68Ga-DOTA-TATE PET/CT for assessment of whole-body tumor burden as a quantitative imaging biomarker in patients with metastatic gastroenteropancreatic neuroendocrine tumors-Reference-Cited by-同舟云学术

Volumetric 68Ga-DOTA-TATE PET/CT for assessment of whole-body tumor burden as a quantitative imaging biomarker in patients with metastatic gastroenteropancreatic neuroendocrine tumors

Published:2022-11 Issue:4 Volume:66 Page:
ISSN:1824-4785
Container-title:The Quarterly Journal of Nuclear Medicine and Molecular Imaging
language:
Short-container-title:Q J Nucl Med Mol Imaging

Author:

OHLENDORF Fiona,HENKENBERENS Christoph,BRUNKHORST Thomas,ROSS Tobias L.,CHRISTIANSEN Hans,BENGEL Frank M.,DERLIN Thorsten

Publisher

Edizioni Minerva Medica

Subject

Radiology, Nuclear Medicine and imaging

Link

https://www.minervamedica.it/pdf.php?cod=R39Y2022N04A0361

Reference32 articles.

1. Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors

2. Prospective Study of 68Ga-DOTATATE Positron Emission Tomography/Computed Tomography for Detecting Gastro-Entero-Pancreatic Neuroendocrine Tumors and Unknown Primary Sites

3. Comparison of abdominal MRI with diffusion-weighted imaging to 68Ga-DOTATATE PET/CT in detection of neuroendocrine tumors of the pancreas

4. Clinical value of 68Ga-DOTATATE-PET/CT compared to stand-alone contrast enhanced CT for the detection of extra-hepatic metastases in patients with neuroendocrine tumours (NET)

5. The added value of 68Ga-DOTA-TATE-PET to contrast-enhanced CT for primary site detection in CUP of neuroendocrine origin

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Defining the optimal segmentation method for measuring somatostatin receptor expressing tumor volume on 68Ga-DOTATATE positron emission tomography/computed tomography to predict prognosis in patients with gastroenteropancreatic neuroendocrine tumors;Nuclear Medicine Communications;2024-05-15

2. Prediction of 177Lu-DOTATATE Therapy Outcomes in Neuroendocrine Tumor Patients Using Semi-Automatic Tumor Delineation on 68Ga-DOTATATE PET/CT;Cancers;2023-12-31

3. The Role of <sup>68</sup>Ga-DOTATATE PET/CT in the Follow-Up of Patients with Pancreatic Neuroendocrine Tumors: a Retrospective Study;Journal of oncology: diagnostic radiology and radiotherapy;2023-06-20

4. Prognostic Value of Somatostatin Receptor-Derived Volumetric Parameters from a Hybrid Standardized Uptake Value Thresholding Method in Patients with 68Ga-DOTATATE-Avid Stage IV Neuroendocrine Neoplasms: A Preliminary Study;Neuroendocrinology;2023-04-21

5. Relevance of Volumetric Parameters Applied to [68Ga]Ga-DOTATOC PET/CT in NET Patients Treated with PRRT;Diagnostics;2023-02-07